Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Daniele Generali
Response Rate as a Potential Surrogate for Survival and Efficacy in Patients Treated With Novel Immune Checkpoint Inhibitors: A Meta-Regression of Randomised Prospective Studies
European Journal of Cancer
Cancer Research
Oncology
The Prolyl Hydroxylase Enzymes Are Positively Associated With Hypoxia-Inducible Factor-1α and Vascular Endothelial Growth Factor in Human Breast Cancer and Alter in Response to Primary Systemic Treatment With Epirubicin and Tamoxifen
Breast Cancer Research
Cancer Research
Oncology
Early Immune Modulation by Single-Agent Trastuzumab as a Marker of Trastuzumab Benefit
British Journal of Cancer
Cancer Research
Oncology
Correction: Everolimus (EVE) and Exemestane (EXE) in Patients With Advanced Breast Cancer Aged ≥ 65 Years: New Lessons for Clinical Practice From the EVA Study
Oncotarget
Oncology
Correction 2: Everolimus (EVE) and Exemestane (EXE) in Patients With Advanced Breast Cancer Aged ≥ 65 Years: New Lessons for Clinical Practice From the EVA Study
Oncotarget
Oncology
Bevacizumab in Small Cell Lung Cancer
Annals of Translational Medicine
Medicine
Tumour Infiltrating Lymphocytes and Immune-Related Genes as Predictors of Outcome in Pancreatic Adenocarcinoma
PLoS ONE
Multidisciplinary
Neoadjuvant Eribulin Mesylate Following Anthracycline and Taxane in Triple Negative Breast Cancer: Results From the HOPE Study
PLoS ONE
Multidisciplinary
Expression of Genes Involved in DNA Repair and Cell Cycle Checkpoint Pathways in Triple Negative Compared to Luminal a Breast Cancer: A Molecular Characterization
Hereditary Cancer in Clinical Practice
Oncology
Genetics
Randomized Phase II Trial of Letrozole and Letrozole Plus Low-Dose Metronomic Oral Cyclophosphamide as Primary Systemic Treatment in Elderly Breast Cancer Patients
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology